InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Lauren Merendino, Chief Commercial Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 8 open-market SEC Form 4 transactions: 0 purchases worth $0 and 8 sales worth $343K, reported from Apr 19, 22 to Feb 17, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 26 | DAWNDay One Biopharmaceuticals, Inc. | SELL | 5.8K | $11.60 | $67K |
| Nov 17, 25 | DAWNDay One Biopharmaceuticals, Inc. | SELL | 3.7K | $8.91 | $33K |
| Aug 18, 25 | DAWNDay One Biopharmaceuticals, Inc. | SELL | 3.8K | $6.77 | $25K |
| May 16, 25 | DAWNDay One Biopharmaceuticals, Inc. | SELL | 3.9K | $6.26 | $25K |
| Jan 18, 23 | MYOVMyovant Sciences Ltd. | SELL | 2.0K | $26.89 | $54K |
| Oct 18, 22 | MYOVMyovant Sciences Ltd. | SELL | 1.7K | $25.20 | $43K |
| Jul 18, 22 | MYOVMyovant Sciences Ltd. | SELL | 1.7K | $12.87 | $22K |
| Apr 19, 22 | MYOVMyovant Sciences Ltd. | SELL | 7.0K | $10.45 | $74K |